SERACTIL

This brand name is authorized in Austria, Poland, Romania, Spain.

Active ingredients

The drug SERACTIL contains one active pharmaceutical ingredient (API):

1	Dexibuprofen UNII 671DKG7P5S - DEXIBUPROFEN
	Dexibuprofen is considered to be the pharmacologically active enantiomer of racemic ibuprofen. Racemic ibuprofen is a non-steroidal substance with antiinflammatory and analgesic effects. Its mechanism of action is thought to be due to inhibition of prostaglandin synthesis.
	Read more about Dexibuprofen

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SERACTIL Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AE14	Dexibuprofen	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	63574
PL	Rejestru Produktów Leczniczych	100098562, 100098585
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63988001, W63988002, W63988003, W63988004, W63988005, W63988006, W63988007, W63988008, W63988009, W63988010